NZ Colorectal Oncology Research Review Issue 31

In this issue:

  -  ctDNA predicts response to neoadjuvant chemoradiotherapy
  -  Capecitabine vs active monitoring in mCRC
  -  Open vs laparoscopic surgery in mid and low rectal cancer
  -  WEE1 inhibition in TP53- and RAS-mutant mCRC
  -  Rectal cancer treatment and outcomes in elderly patients
  -  Robotic-assisted total mesorectal excision for rectal cancer
  -  Nivolumab plus ipilimumab in mCRC
  -  Panitumumab in RAS wild-type mCRC
  -  TAS-116 plus nivolumab in patients with CRC
  -  Biomarkers of immune checkpoint inhibition in MMR-deficient CRC

Please login below to download this issue (PDF)